Medivance

What Medivance does

Medivance, Inc. is a medical device company that develops, manufactures, and sells temperature management products for hospital-based critical care. Founded in 1998 and headquartered in Louisville, Colorado (later integrated into Becton, Dickinson and Company following the 2011 acquisition), Medivance is the originator of the Arctic Sun™ Temperature Management System, which delivers non-invasive Targeted Temperature Management (TTM) for adult and pediatric patients, including neonates, through automated monitoring and micro-adjustments that maintain core temperature within narrow therapeutic ranges. The system is paired with proprietary ArcticGel™ hydrogel pads (available in neonatal, pediatric, and adult sizes) that are the only consumables compatible with the Arctic Sun hardware, creating a razor/blade revenue architecture. Supporting modules include Arctic Sun™ Analytics for post-therapy visualization, protocol compliance benchmarking, and case debriefs, and Arctic Sun™ Connectivity for wireless EMR integration.

Medivance's go-to-market is enterprise field sales directed at hospitals and healthcare facilities, executed through BD's global distribution infrastructure spanning North America, South America, Europe, Middle East, Africa, and Asia Pacific. Pricing is quote-based, set through direct engagement with BD representatives, typically under multi-year contracts. Customer segments are acute care hospitals with intensive care units, emergency departments, and neonatal ICUs treating cardiac arrest, brain injury, hypoxic-ischemic encephalopathy, and post-surgical recovery patients. As a wholly-owned subsidiary brand of Becton, Dickinson and Company (NYSE: BDX), Medivance operates within a large publicly-traded medical technology parent and no longer publishes standalone financial data.

Name

Medivance

Legal name

Becton, Dickinson and Company

Website

https://medivance.com

Company type

Public

Founded year

1897

Operating status

Operating

Headcount range

51–100 employees

Short description

Medivance develops non-invasive Targeted Temperature Management systems (Arctic Sun devices and ArcticGel hydrogel pads) for hospitals treating critically ill and neonatal patients. Acquired by BD in 2011, it sells globally through direct enterprise field sales and recurring proprietary consumables.

Ownership category

akta.pro rank

Product category

Medical Devices - Targeted Temperature Management

NAICS

Automatic Environmental Control Manufacturing for Residential, Commercial, and Appliance Use (334512)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Continuous Temperature & Fever Monitoring (Wearable Thermometry) (HLAHACAK)

Keywords

• Targeted temperature management
• Patient temperature control
• Critical care medical devices
• Neonatal cooling therapy
• Hospital thermal regulation

Headquarters

HQ city

Louisville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Medical Device Hardware Sales: Sale of Arctic Sun™ temperature management systems (devices) to hospitals and healthcare facilities
2. Proprietary Consumables (ArcticGel Pads): Recurring revenue from proprietary hydrogel pads that are required for use with the Arctic Sun device. The system is only compatible with ArcticGel pads, creating a recurring consumables revenue stream.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Medivance develops and manufactures the Arctic Sun™ Temperature Management System (Stat and 5000 models) and proprietary ArcticGel™ hydrogel pads for non-invasive Targeted Temperature Management (TTM) in critical care. Hospitals use the platform to precisely control core body temperature in adult, pediatric, and neonatal patients for conditions including cardiac arrest, brain injury, and neonatal hypoxic-ischemic encephalopathy. The full BD TTM™ Solution bundles the device, proprietary consumable pads, analytics, EMR connectivity, training, and service into a comprehensive temperature management offering.

Product overview

The BD TTM (Targeted Temperature Management) Solution is a unified platform combining hardware, software, analytics, and proprietary consumables for non-invasive temperature control in critical care. The core offerings include the Arctic Sun™ Temperature Management System (encompassing the Stat and 5000 models) and ArcticGel™ Pads (available in Neonatal, Pediatric, and Adult sizes). Supporting modules include Arctic Sun™ Analytics for data visualization and compliance tracking, and Arctic Sun™ Connectivity for wireless EMR integration. The system is indicated for monitoring and controlling patient temperature in adult and pediatric patients of all ages.

Differentiator

Problem solved

Functional benefit

Brands

• Arctic Sun: Temperature management system product line including Arctic Sun Stat and Arctic Sun 5000 for Targeted Temperature Management in critical care
• ArcticGel
• BD TTM Solution

Products and services

• Arctic Sun™ Stat Temperature Management System Hardware device for non-invasive monitoring and automatic temperature control in adult and pediatric patients in critical care settings, sold to hospitals and healthcare facilities.
• Arctic Sun™ 5000 Temperature Management System Temperature management hardware device for monitoring and controlling patient core temperature within a narrow therapeutic range for appropriate patients in critical care.
• ArcticGel™ Pads Proprietary, skin-friendly hydrogel pads (available in neonatal, pediatric, and adult sizes) using patented hydrogel technology to enable safe, effective cooling and warming for precise core temperature control. Sold as recurring consumables for use with Arctic Sun systems.
• Arctic Sun™ Analytics Software analytics offering that visualizes trends, benchmarks, and case debriefs to enable data-driven decisions against TTM protocols and support compliance tracking for hospitals.
• Arctic Sun™ Connectivity Connectivity module providing wireless EMR integration so that Arctic Sun therapy data can flow into hospital electronic medical record systems.
• BD TTM™ Solution Comprehensive Targeted Temperature Management solution bundling hardware, software, training, service, analytics, connectivity, and proprietary ArcticGel pads for non-invasive monitoring and temperature control of neonate, pediatric, and adult patients.

Quantifiable outcome

• Up to 72% of eligible patients never receive this potentially life-changing intervention
• +1 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Stryker (Gaymar): Through its Gaymar acquisition, Stryker provides patient warming and surface temperature management systems used in hospitals, overlapping with the hospital temperature-control category served by Arctic Sun.
• Gentherm: Gentherm manufactures patient warming and temperature management products for surgical and critical care settings, competing with BD's Arctic Sun platform for hospital temperature-management budgets.
• Smiths Medical (Level 1): Smiths Medical's Level 1 fluid warmers and patient temperature products serve perioperative and critical care, overlapping with BD's hospital temperature-management offering.
• 3M (Bair Hugger): 3M's Bair Hugger patient warming system is widely adopted in surgical and perioperative settings, addressing adjacent hospital temperature-management needs where Arctic Sun also competes.

Direct peers

• Cincinnati Sub-Zero (CSZ): CSZ manufactures hyper-hypothermia blanket systems and normothermia units used for therapeutic cooling and warming in ICUs, directly competing with Arctic Sun in TTM.
• ZOLL Medical (Thermogard): ZOLL (now part of Asahi Kasei) sells the Thermogard XP intravascular cooling system, a direct competitor to Arctic Sun in Targeted Temperature Management for cardiac arrest and critical care.

Emerging players

• Life Recovery Systems (ThermoSuit): Life Recovery Systems makes the ThermoSuit rapid cooling system for therapeutic hypothermia, an emerging alternative surface-cooling modality competing with Arctic Sun.
• Belmont Medical (Belmont Hyperthermia Pump): Belmont Medical produces rapid infusion and fluid warming/temperature-management devices used in trauma and critical care, an adjacent competitor in hospital temperature regulation.
• EM-MED: EM-MED supplies patient cooling products (e.g., ice/water cooling blankets) for emergency and critical care, offering lower-cost alternatives that compete with Arctic Sun in select markets.
• BrainCool: BrainCool develops surface and intranasal cooling technologies (e.g., RhinoChill, Braincool System) for TTM and oncology, representing an emerging alternative to Medivance's Arctic Sun.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/BDandCo
• YouTubeyoutube.com/channel/UCPGmutY43EjP_3ijOugNGnA
• Facebookfacebook.com/BectonDickinsonandCo
• LinkedInlinkedin.com/company/bd1
• Instagraminstagram.com/becton_dickinson

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds4 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medivance